Trials / Not Yet Recruiting
Not Yet RecruitingNCT07263555
Clinical Performance of Alkasite-based Restorations in Children
Clinical Performance of Alkasite-Based Resin Versus Nanohybrid Composite Resin Restorations for Occlusal Carious Lesions in Primary Molars: A Randomized Clinical Trial
- Status
- Not Yet Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 50 (estimated)
- Sponsor
- Cairo University · Academic / Other
- Sex
- All
- Age
- 4 Years – 6 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study is to evaluate and compare the clinical performance of alkasite-based resin and nanohybrid composite resin materials in the restoration of occlusal carious lesions in primary molars of children.
Detailed description
This randomized clinical trial aims to evaluate and compare the clinical performance of an alkasite-based resin restorative material (Cention N®) and a nanohybrid composite resin (TPH Spectra ST Universal Composite) in restoring occlusal carious lesions (Class I) in primary molars among children aged 4-6 years. Participants will be randomly allocated in a 1:1 ratio into two parallel groups and followed for a period of 12 months. The primary outcome will be the incidence of secondary caries assessed at 3, 6, and 12 months using the United States Public Health Service (USPHS) criteria, which grades restorations from Alpha (ideal/excellent) to Delta (failure). Secondary outcomes will include the evaluation of restoration fracture, marginal adaptation, marginal discoloration, surface roughness, and retention, all assessed at the same intervals using the same USPHS criteria.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Alkasite-based composite restorations | Alkasite-based restorations will be used in the treatment of class I carious lesion in primary molars. |
| OTHER | Nano-hybrid resin composite | Nanohybrid composite will be used in the restoration of Class I carious lesions in primary molars. |
Timeline
- Start date
- 2026-02-01
- Primary completion
- 2027-02-01
- Completion
- 2027-02-01
- First posted
- 2025-12-04
- Last updated
- 2025-12-04
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT07263555. Inclusion in this directory is not an endorsement.